iRadimed Corporation (IRMD) News

iRadimed Corporation (IRMD): $36.84

-0.01 (-0.03%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter IRMD News Items

IRMD News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

IRMD News Highlights

  • For IRMD, its 30 day story count is now at 4.
  • Over the past 15 days, the trend for IRMD's stories per day has been choppy and unclear. It has oscillated between 2 and 2.

Latest IRMD News From Around the Web

Below are the latest news stories about Iradimed Corp that investors may wish to consider to help them evaluate IRMD as an investment opportunity.

IRADIMED CORPORATION to Hold 2021 Third Quarter Financial Results Conference Call on October 29th

WINTER SPRINGS, Fla., Oct. 08, 2021 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2021 third quarter financial results before the market opens on Friday, October 29 th . IRADIMED management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions.

Intrado Digital Media | October 8, 2021

Next-generation IV Infusion Pumps Market to Witness Huge Growth by Key Players: BD, Fresenius Kabi, Terumo, Medtronic, Baxter International, Hospira, iRadimed, Zyno Medical, Nipro, Summit Medical, Smiths Medical, Gamastech

Global Next-generation IV Infusion Pumps Market 2021-2027, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion

OpenPR | September 23, 2021

IRadimed's (NASDAQ:IRMD) Returns On Capital Not Reflecting Well On The Business

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

Yahoo | September 16, 2021

IRadimed Corporation's (NASDAQ:IRMD) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

IRadimed's (NASDAQ:IRMD) stock is up by a considerable 19% over the past three months. However, we decided to pay...

Yahoo | August 2, 2021

IRADIMED CORPORATION Announces Second Quarter 2021 Financial Results

Reports second quarter 2021 revenue of $9.8 million, GAAP diluted EPS of $0.12 and non-GAAP diluted EPS of $0.14Issues Q3 and full year 2021 financial guidance WINTER SPRINGS, Fla., July 30, 2021 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system, and non-magnetic patient vital signs monitoring sys

Yahoo | July 30, 2021

Products in Magnetic Resonance Imaging (MRI) Systems Markets Are Used To Diagnose and Monitor Almost Every Type of Disease

Launch of MRI compatible monitoring systems is expected to propel growth of the magnetic resonance imaging (MRI) systems market. In December 2019, Iradimed Corporation announced completion of the CE Mark renewal process for its MRI compatible patient vital signs monitoring

OpenPR | July 28, 2021

IRadimed (IRMD) Earnings Expected to Grow: Should You Buy?

IRadimed (IRMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | July 23, 2021

iRadimed (IRMD) Stock Jumps 11.3%: Will It Continue to Soar?

iRadimed (IRMD) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

Yahoo | July 14, 2021

IRADIMED CORPORATION to Hold 2021 Second Quarter Financial Results Conference Call on July 30th

WINTER SPRINGS, Fla., July 07, 2021 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2021 second quarter financial results before the market opens on Friday, July 30th. IRADIMED management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions. Individuals interested in listening to the conference call may do so by dialing 1-844-413-1781 for domestic callers, or 1-716-

Yahoo | July 7, 2021

Here's What Could Help iRadimed (IRMD) Maintain Its Recent Price Strength

iRadimed (IRMD) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

Yahoo | June 23, 2021


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7857 seconds.